MaxLinear Introduces New Quad-Channel Optical Driver for 100Gbps Ultra-Long-Haul Coherent Optical Systems

MaxLinear Inc., a leading provider of radio frequency (RF) and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, data center, metro, long-haul fiber networks, and wireless infrastructure, today announced the MxL9207, a quad-channel Lithium Niobate (LiNbO3) Mach-Zehnder (MZ) modulator driver for next-generation 100Gbps optical DWDM coherent systems. The MxL9207 supports DP-QPSK/BPSK coherent design for ultra-long-haul optical networking applications, which have the most challenging systems requirements.

The MxL9207 features a per-channel data rate of 32Gbaud with low jitter and low power dissipation performance. The 7.5Vpp output swing capability makes it an ideal fit for 100Gbps ultra-long-haul and long-haul applications.  The device features output crossing-point and output amplitude control. It also has an integrated bias-tee to maintain optimal power dissipation. The 19mm x 13mm SMT package makes it suitable for new and legacy 100Gbps coherent designs.

The company also announced that the MxL9207 is being evaluated by leading telecommunication equipment OEMs for telecom line-side 100Gbps coherent systems.

“The demand for 100Gbps coherent systems for ultra-long-haul and long-haul optical network applications is growing rapidly. The MxL9207 driver provides industry leading combination of rich features and high output-voltage driving capability, which meets the highest performance requirements critical to next-generation infrastructure deployments,” said Dr. Kishore Seendripu, MaxLinear CEO and President.”

Source: http://www.maxlinear.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.